Is Royalty Pharma plc (RPRX) The Most Profitable Biotech Stock To Buy Right Now?
Post Content
Semiramis Paliou sticks to bulker strategy as Diana Shipping rings in IPO milestone
Anniversary comes as dry bulk player dips toe in new markets and its shares face pressure
Hutchison Ports deal delayed as Hong Kong billionaire Li Ka-Shing reviews options
Pro-Beijing media have criticized the deal, calling it a betrayal of China
G2 Ocean pushes up profit despite lower rates for its 120 bulkers
Gearbulk and Grieg pool venture boosted by lower tax bill for 2024